Edward Lain, MD
Enriched profileBoard-Certified Dermatologist and Chief Medical Officer · Sanova Dermatology
Edward Lain is Board-Certified Dermatologist and Chief Medical Officer at Sanova Dermatology. OpenAlex indexes 145 publications with 1,284 citations (h-index 19); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Edward "Ted" Lain, MD, is Board-Certified Dermatologist and Chief Medical Officer at Sanova Dermatology. The public record shows 145 publications with 1,284 citations (h-index 19), centered on Acne and Rosacea Treatments and Effects, Dermatology and Skin Diseases, Dermatologic Treatments and Research. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 47 companies.
- Most recent indexed publication: 2024 · Dermatology and therapy
- Top research focus: Acne and Rosacea Treatments and Effects
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 47 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 36.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Sponsor: Novartis Pharmaceuticals
Industry payments
Updated 27 Aug 2026
47 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202547 payments$97,458openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202557 payments$83,761openpaymentsdata.cms.gov ↗
- UCB, Inc.Program year202590 payments$70,619openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
90.2%Porphyrin Precursor88.9%Aminolevulinic acid hcl100%Part B, office-administered≥19 patientsCalcineurin inhibitor0.8%Tacrolimus100%Part D≥28 patientsAnti-infectives
3.8%Azole Antifungal2.4%Ketoconazole92%Fluconazole8%Part D<11 patientsTetracycline-class Drug0.9%Doxycycline Hyclate62%Minocycline Hcl38%Part D<11 patientsDermatology
2.5%Corticosteroid1.5%Triamcinolone Acetonide55%Triamcinolone acetonide45%Part D + Part B≥41 patientsInterleukin-4 Receptor alpha Antagonist0.4%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses.
Dermatology and therapy
Review2024 - Real-World Clinical Experience With an Allograft Adipose Matrix for Replacing Volume Loss in Face, Hands, and Body.
Journal of cosmetic dermatology
Case Report2024 - Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series.
Dermatology and therapy
Article2022 - Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis.
Clinical drug investigation
Clinical Trial2018
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/edward-lain-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Instagram
instagram.com/drtedlain
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/in/drtedlain
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Instagram
Instagram: @drtedlain (Dr. Ted Lain MD & MBA, FAAD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - X / Twitter
X (Twitter): @DrLain
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sanovadermatology.com ↗
- MBA
Rice University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sanovadermatology.com ↗ - Dermatology residency
University of Arkansas for Medical Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atxresearch.com ↗ - Internal Medicine internship
University of Arkansas for Medical Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atxresearch.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologytimes.com ↗
Editorial & leadership roles
journal and society appointments- Executive Director and Principal Investigator
Austin Institute for Clinical Research (AICR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atxresearch.com ↗ - Physician Trainer for Allergan (BOTOX Cosmetic and JUVEDERM)
sole Allergan trainer based in Austin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sanovadermatology.com ↗ - Co-chair
Science of Skincare Summit (with Patricia Farris, MD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sanovadermatology.com ↗
Secondary affiliations
appointments beyond the home institution- Affiliated physician
St. David's North Austin Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Affiliated physician
Ascension Seton Northwest / Dell Seton Medical Center at the University of Texas
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthcare.ascension.org ↗
Media & interviews
press, podcasts and appearances- Interviewed for "Under Your Skin" video series by Nicholas Brownstone
MD (dermsquared.com)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermsquared.com ↗ - Featured guest
JCAD (Journal of Clinical and Aesthetic Dermatology) podcast: "Long-Term Results of Deuruxolitinib for Alopecia Areata"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jcadonline.com ↗ - Featured guest
Dermatology Times video segment "Personal Care Products With Ted Lain, MD, MBA"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologytimes.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan